COMPUMED, INC. RETAINS PORTER, LEVAY & ROSE AS INVESTOR RELATIONS COUNSEL

LOS ANGELES, July 6 2005 -- CompuMed, Inc. (CMPD.OB) -- a medical informatics company serving the healthcare community with diagnostic software solutions, today announced that it has retained Porter, LeVay & Rose as its investor relations and financial communications agency. Based in New York City, Porter, LeVay & Rose, is a 33-year-old, full-service firm that represents a wide variety of public and private companies and financial institutions in the United States and abroad.

"Our goal is to increase awareness about CompuMed's significant potential for investors," said CompuMed CEO Jerry McLaughlin. "We are pleased that Porter, LeVay & Rose will represent CompuMed, and we are confident that their experience and expertise will help us communicate effectively with the investment and business community."

Michael Porter, President of Porter, LeVay & Rose, Inc., said, "We are very pleased to be a part of CompuMed's team, and we believe that the Company's CardioGram and OsteoGramŽ products afford significant prospects for growth."

About CompuMed:

Founded in 1973, CompuMed, Inc. (BB:CMPD) is a leading provider of computer-aided telemedicine and diagnostics technology. The Company's core products are the OsteoGram and CardioGram systems. The OsteoGram, which is cleared by the FDA for commercial use, is an accurate and precise technology for low-cost osteoporosis testing. The CardioGram system remotely interprets electrocardiograms and is used by private practice, government and corporate healthcare providers nationwide. CompuMed is headquartered in Los Angeles. Visit CompuMed at www.compumed.net or call (310) 258-5000.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning CompuMed's plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission. All such forward-looking statements are expressly qualified by these cautionary statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.

CONTACT: Erik Deutsch - Tellem Worldwide, +1 (310) 479-6111 x.15, edeutsch@tellem.com